Two Sigma Advisers
CUE icon

Two Sigma Advisers’s Cue Biopharma CUE Stock Holding History

Two Sigma Advisers’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-903
Closed -$98.9K – 2425
2023
Q2 		$98.9K Sell
903
-200
-18% -$23.5K ﹤0.01% 2217
2023
Q1 		$118K Sell
1,103
-2,527
-70% -$241K ﹤0.01% 2359
2022
Q4 		$310K Sell
3,630
-2,480
-41% -$227K ﹤0.01% 2058
2022
Q3 		$409K Sell
6,110
-1,027
-14% -$88.3K ﹤0.01% 1928
2022
Q2 		$533K Buy
7,137
+287
+4% +$33.6K ﹤0.01% 1889
2022
Q1 		$1M Sell
6,850
-723
-10% -$153K ﹤0.01% 1637
2021
Q4 		$2.57M Buy
7,573
+840
+12% +$325K 0.01% 1064
2021
Q3 		$2.94M Sell
6,733
-3,200
-32% -$1.12M 0.01% 1047
2021
Q2 		$3.47M Sell
9,933
-2,270
-19% -$880K 0.01% 1035
2021
Q1 		$4.47M Buy
12,203
+513
+4% +$211K 0.01% 895
2020
Q4 		$4.39M Buy
11,690
+1,910
+20% +$763K 0.01% 878
2020
Q3 		$4.42M Buy
9,780
+5,193
+113% +$2.99M 0.01% 809
2020
Q2 		$3.37M Buy
4,587
+4,234
+1,199% +$3.07M 0.01% 960
2020
Q1 		$150K Buy
+353
New +$171K ﹤0.01% 2236

Other funds holding CUE

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers's CUE Position: Q3 2023 in Review

Two Sigma Advisers sold out of Cue Biopharma (CUE) in Q3 2023, closing a stake of 903 shares — an estimated $98.9K sold.

Two Sigma Advisers first reported a position in CUE in Q1 2020 and held it in 14 quarters. The position peaked at $4.47M in Q1 2021. 75 funds tracked by Wall St. Rank hold CUE as of Q3 2023.

  • Two Sigma Advisers reported no remaining Cue Biopharma position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 903 Cue Biopharma shares in Q3 2023, an estimated $98.9K.
  • Two Sigma Advisers first reported a position in Cue Biopharma in Q1 2020 and held it in 14 quarters.
  • Two Sigma Advisers's Cue Biopharma position peaked at $4.47M in Q1 2021.
  • 75 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2023.

Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.